Abstract
In the United States, more than 200,000 patients undergo dialysis and 70,000 patients have functioning kidney transplants.1 The prevalence of end-stage renal disease (ESRD) is increasing at 7% to 9% annually, making it likely that more than 350,000 patients with ESRD will be cared for in the United States by the year 2010. The annual incidence of ESRD is 242 cases per million population, although Blacks have a disproportionately high incidence (758 per million population per year) as compared with Whites (180 per million population per year).1 Diabetes accounts for 35% of newly diagnosed cases of ESRD, making it the most common cause of renal failure, followed by hypertension (30%). Other causes of ESRD include glomerulopathy, cystic and interstitial renal disease, and obstructive uropathy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
US renal data system. In: USRDS 1997 Annual Data Report. Bethesda, Md: The National Institute of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 1997.
Friedman EA. End-stage renal disease therapy: an American success story. JAMA 1996;275:1118–1122.
Pastan S, Bailey J. Dialysis therapy. N Engl J Med 1998;338: 1428–1437.
Annual Report of the U.S. Scientific Registry for Transplant Recipients and the Organ Procurement and Transplantation Network-Transplant Data 1988–1996. Richmond, Va: UNOS, and Rockville, Md: Division of Transplantation, Office of Special Programs, Health Resources and Services Administration, US Department of Health and Human Services, 1997.
Port FK, Wolfe RA, Mauger EA, et al. Comparison of survival probabilities for dialysis patients vs. cadaveric renal transplant recipients. JAMA 1993;270:1339–1343.
Knechtle SJ, Pirsch JD, D’Alessandro AM, et al. Renal transplantation at the University of Wisconsin in the cyclosporine era. In: Terasaki PI, Cecka JM, eds. Clinical Transplants 1993. Los Angeles: UCLA Tissue Typing Laboratory, 1994: 211–218.
Foley RN, Parfrey PS, Sarnak MJ: Clinical epidemiology of cardiovascular disease in chronic renal disease. Am I Kidney Dis 1998;32(suppl 3 ): S112 - S119.
Laupacis A, Keown P, Pus N, et al. A study of the quality of life and cost-utility of renal transplantation. Kidney Int 1996;50: 235–242.
Evans RW, Manninen DL, Dugan MK, et al. The Kidney Transplant Health Insurance Study: Final Report. Seattle: Battelle Human Affairs Research Centers, 1990.
Russell JD, Beecroft ML, Ludwin D, et al. The quality of life in renal transplantation-a prospective study. Transplantation 1992; 54: 656–660.
Krmar RT, Eymann A, Ramirez JA, et al. Quality of life after kidney transplantation in children. Transplantation 1997;64:540–541.
Kolff WJ. The first clinical experience with the artificial kidney. Ann Intern Med 1965;62:608.
Quinton WE, Dillard D, Schribner BH. Cannulation of blood vessels for prolonged hemodialysis. Trans Am Soc Artif Intern Organs 1960;6:104.
Thadhani R, Pascual M, Bonventre IV. Acute renal failure. N Engl J Med 1996; 334: 1448–1460.
Manns M, Sigler MH, Teehan BP. Continuous renal replacement therapies: an update. Am J Kidney Dis 1998; 32: 185–207.
Williams RA, Hollander L, Benyon RS, et al. Principles of vascular access surgery. In: Wilson SE, Veith FJ, Hobson RW, Williams RA, ed. Vascular Surgery: Principles and Practice. New York: McGraw-Hill, 1987: 857–872.
Mehta S. Statistical summary of clinical results of vascular access procedures for hemodialysis. In: Sommer BG, Henry ML, eds. Vascular Access for Hemodialysis-II. W.L. Gore Associates, Inc., Precept Press, 1991: 145–157.
Kasiske BL, Ramos EL, Gaston RS, et al., for the Patient Care and Education Committee of the American Society of Transplant Physicians. The evaluation of renal transplant candidates: clinical practice guidelines. J Am Soc Nephrol 1995;6:1–34.
Ramos EL, Tisher CC. Recurrent diseases in the kidney transplant. Am J Kidney Dis 1994;24:142–154.
Odorico JS, Knechtic SJ, Rayhill SC, et al. The influence of native nephrectomy on the incidence of recurrent disease following renal transplantation for primary glomerulonephritis. Transplantation 1996;61:228–234.
Sayegh MH, Turka LA. The role of T-cell costimulatory activation pathways in transplant rejection. N Engl J Med 1998;338: 1813–1821.
Cecka JM. The UNOS Scientific Renal Transplant Registry-ten years of kidney transplants. In: Cecka JM, Terasaki PI, eds. Clinical Transplants 1997. Los Angeles: UCLA Tissue Typing Laboratory, 1998: 1–14.
Kissmeyer-Nielsen F, Olsen S, Petersen VP, et al. Hyperacute rejection of kidney allografts, associated with pre-existing humoral antibodies against donor cells. Lancet 1966;2:662–665.
Patel R, Terasaki PI. Significance of the positive crossmatch test in kidney transplantation. N Engl J Med 1969; 280: 735–739.
Van der Werf WJ, D’Alessandro AM, Hoffmann RM, et al. Procurement, preservation, and transport of cadaver kidneys. Surg Clin North Am 1998;78:41–54.
Cecka JM, Terasaki PI. Optimal use for older donor kidneys: older recipients. Transplant Proc 1995;27:801–802.
Nathan HM, Jarrell BE, Broznik B, et al. Estimation and characterization of the potential renal organ donor pool in Pennsylvania. Transplantation 1991;51:142–149.
D’Alessandro AM, Hoffmann RM, Belzer FO. Non-heart-beating donors: one response to the organ shortage. Transplant Rev 1995; 9: 168–176.
Chen EP, Bittner HB, Kendall SW, et al. Hormonal and hemodynamic changes in a validated animal model of brain death. Crit Care Med 1996;24:1352–1359.
Novitzky D, Wicomb WN, Cooper DKC, et al. Electrocardiographic, hemodynamic and endocrine changes occurring during experimental brain death in the chacma and baboon. J Heart Transplant 1984;4:63–69.
Griepp RB, Stinson EB, Clark DA, et al. The cardiac donor. Surg Gynecol Obstet 1971;133:792–798.
D’Alessandro AM, Hoffmann RM, Knechtic SJ, et al. Successful extrarenal transplantation from non-heart-beating donors. Transplantation 1995;59:977–982.
Politano VA, Leadbetter WF. J Urol 1958; 79: 932–941.
Hanto DW, Simmons RL. Renal transplantation: clinical considerations. Radiol Clin North Am 1987;25:239–248.
Gruessner RW, Fasola C, Benedetti E, et al. Laparoscopic drainage of lymphoceles after kidney transplantation: indications and limitations. Surgery 1995;117:288–295.
Sankari BR, Geisinger M, Zelch M, et al. Post-transplant renal artery stenosis: impact of therapy on long-term kidney function and blood pressure control. J Urol 1996;155:1860–1864.
D’Alessandro AM, Pirsch JD, Knechtle SJ, et al. Living unrelated renal donation: the University of Wisconsin experience. Surgery 1998;124:604–611.
Ross LF, Rubin DT, Siegler M, et al. Ethics of a paired-kidneyexchange program. N Engl J Med 1997;336:1752–1755.
Flowers JL, Jacobs S, Cho E, et al. Comparison of open and laparoscopie live donor nephrectomy. Ann Surg 1997;226:483–490.
Ratner LE, Kavoussi LR, Sroka M, et al. Laparoscopie assisted live donor nephrectomy-a comparison with the open approach. Transplantation 1997;63:229–233.
Solez K, Axelsen RA, Benediktsson H, et al. International standardization of criteria for the histologic diagnosis of renal allograf t rejection: the Banff working classification of kidney transplant pathology. Kidney Int 1993;44:411–422.
Pirsch JD, Friedman R. Primary care of the renal transplant patient. J Gen Intern Med 1994;9:29–37.
Mihatsch MJ, Thiel G, Spichtin HP, et al. Morphological findings in kidney transplants after treatment with cyclosporine. Transplant Proc 1983;15:2821
Myers BD, Ross J, Newton L, et al. Cyclosporine-associated chronic nephropathy. N Engl J Med 1984;311:699–705.
Svenson K, Bohman SO, Hallgren R. Renal interstitial fibrosis and vascular changes: occurrence in patients with autoimmune diseases treated with cyclosporine. Arch Intern Med 1986;146: 2007–2010.
Rocher LL, Milford EL, Kirkman RL, et al. Conversion from cyclosporine to azathioprine in renal allograft recipients. Transplantation 1984;38:669–674.
Lorber MI, Flechner SM, Van Buren CT, et al. Cyclosporine, azathioprine, and prednisone as treatment for cyclosporine-induced nephrotoxicity in renal transplant recipients. Transplant Proc 1985;17:282–285.
Markell MS, Friedman EA. Hyperlipidemia after organ transplantation. Am J Med 1989;87(5N):61N–67N.
Penn I. Cancers complicating organ transplantation. N Engl J Med 1990; 323: 1767–1769.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer Science+Business Media New York
About this chapter
Cite this chapter
Knechtle, S.J. (2001). Kidney Transplantation and Dialysis Access. In: Norton, J.A., et al. Surgery. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-57282-1_65
Download citation
DOI: https://doi.org/10.1007/978-3-642-57282-1_65
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-63239-6
Online ISBN: 978-3-642-57282-1
eBook Packages: Springer Book Archive